Suppr超能文献

飞秒激光辅助角膜散光切开术治疗角膜移植术后散光: 光轴向量分析。

IntraLase-enabled astigmatic keratotomy for post-keratoplasty astigmatism: on-axis vector analysis.

机构信息

Department of Ophthalmology and Vision Sciences, Toronto Western Hospital, University of Toronto, Ontario, Canada.

出版信息

Ophthalmology. 2010 Jun;117(6):1228-1235.e1. doi: 10.1016/j.ophtha.2009.10.041. Epub 2010 Feb 16.

Abstract

PURPOSE

To determine the refractive predictability, stability, efficacy, and complication rate of femtosecond laser-enabled astigmatic keratotomy for post-keratoplasty astigmatism.

DESIGN

A retrospective case series (pilot study).

PARTICIPANTS

Thirty-seven eyes of 34 patients.

METHODS

All eyes underwent IntraLase-enabled astigmatic keratotomy for high astigmatism (>5 diopters [D]) after penetrating keratoplasty.

MAIN OUTCOME MEASURES

Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), manifest refraction, higher-order aberrations, and complications.

RESULTS

Mean follow-up was for 7.2 months. Uncorrected visual acuity improved from a mean of 1.08+/-0.34 logarithm of the minimum angle of resolution preoperatively to a mean of 0.80+/-0.42 postoperatively (P=0.0016). Best-corrected visual acuity improved from a mean of 0.45+/-0.27 preoperatively to 0.37+/-0.27 postoperatively (P=0.018). The defocus equivalent was significantly reduced by more than 1 D (P=0.025). The value of absolute astigmatism was reduced from 7.46+/-2.70 D preoperatively to 4.77+/-3.29 D postoperatively (P=0.0001). Higher-order aberrations were significantly increased. The efficacy index was 0.6+/-0.6. There were no cases of perforation, wound dehiscence, or infectious keratitis. Three eyes (8%) experienced an episode of graft rejection. Overcorrection occurred in 9 eyes (24%).

CONCLUSIONS

IntraLase-enabled astigmatic keratotomy is an effective treatment for high astigmatism after penetrating keratoplasty with an encouraging refractive predictability. Future studies may help refine the treatment parameters required to achieve reduction of cylinder with greater accuracy.

摘要

目的

确定飞秒激光辅助散光性角膜切开术治疗穿透性角膜移植术后散光的预测性、稳定性、疗效和并发症发生率。

设计

回顾性病例系列(初步研究)。

参与者

34 名患者的 37 只眼。

方法

所有眼均因穿透性角膜移植术后高散光(>5 屈光度[D])行飞秒激光辅助散光性角膜切开术。

主要观察指标

未矫正视力(UCVA)、最佳矫正视力(BCVA)、验光、高阶像差和并发症。

结果

平均随访 7.2 个月。未矫正视力从术前平均 1.08+/-0.34 最小分辨角对数视力提高到术后平均 0.80+/-0.42(P=0.0016)。最佳矫正视力从术前平均 0.45+/-0.27 提高到术后 0.37+/-0.27(P=0.018)。等效球镜度数降低超过 1 D(P=0.025)。绝对散光值从术前 7.46+/-2.70 D 降低到术后 4.77+/-3.29 D(P=0.0001)。高阶像差显著增加。疗效指数为 0.6+/-0.6。无穿孔、伤口裂开或感染性角膜炎病例。3 只眼(8%)发生移植物排斥反应。9 只眼(24%)发生过矫。

结论

飞秒激光辅助散光性角膜切开术是治疗穿透性角膜移植术后高散光的有效方法,具有良好的预测性。未来的研究可能有助于进一步优化达到准确降低散光所需的治疗参数。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验